CAP V Mauritius Limited managed by The Carlyle Group Inc. (NasdaqGS:CG) agreed to acquire 5% stake in Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) for CNY 1.8 billion on September 1, 2020. Qiuning (Frank) Sun of Latham & Watkins acted as the legal advisor to the Carlyle Group.